Navigation Links
Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against Gleevec(R) as first-line treatment in chronic myeloid leukemia patients
Date:10/19/2009

EAST HANOVER, N.J., Oct. 20 /PRNewswire/ -- Novartis announced today that Tasigna® (nilotinib) 200 mg capsules met its primary endpoint in the first head-to-head comparison with the company's groundbreaking drug Gleevec® (imatinib mesylate) tablets*. Tasigna produced faster and deeper responses than Gleevec when given as first-line therapy for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Tasigna was well tolerated in the study (5,6).

The Phase III clinical trial, Evaluating Nilotinib Efficacy and Safety in Clinical Trials of Newly Diagnosed Ph+ CML Patients (ENESTnd), is the largest global randomized comparison of two oral therapies ever conducted in newly diagnosed Ph+ CML patients. Designed to detect a difference in major molecular response (MMR) between Tasigna and Gleevec after 12 months of treatment, it is also the first registration study in which molecular traces of a key biomarker specific to Ph+ CML have been used as a primary endpoint for regulatory review. The comparison study also met its secondary endpoint, a difference in complete cytogenetic response (CCyR) in favor of Tasigna (5,6).

"We developed Tasigna to be a potent and selective inhibitor of Bcr-Abl, with the goal of eliminating the underlying cause of Ph+ CML. We now know that Tasigna reduces the level of Bcr-Abl faster and to a lower level than Gleevec, with profound implications for improving patients' outcomes," said David Epstein, President and CEO of Novartis Oncology and Novartis Molecular Diagnostics. "Molecular monitoring enables us to evaluate whether patients have achieved this deep level of CML residual disease, reducing the fundamental biomarker of leukemia to nearly undetectable levels."

The blood test used to determine molecular response can detect a single cell containing traces of Bcr-Abl in up to one mil
'/>"/>

SOURCE Novartis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
2. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
3. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
4. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
5. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
6. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
7. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
8. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
9. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
10. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
11. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... PLAINFIELD, N.J. , Aug. 20, 2014 PTC Therapeutics, ... will participate at two upcoming investor conferences: - ... Seasons Hotel in Boston on Wednesday, ... Biotech Conference at The Mandarin Oriental Boston on Thursday, September ... present a company update at the Bank of America Merrill ...
(Date:8/20/2014)... YORK , Aug. 20, 2014 /PRNewswire/ ... research report is available in its catalogue: ... in Canada, Key Trends and Opportunities to ... Synopsis The report provides ... into the Canadian personal accident and health ...
(Date:8/20/2014)... , Aug. 20, 2014 Children ... can receive vaccinations to help prevent disease. The ... vaccination for all adults, but currently, many adults ... August is National Immunization Awareness Month, and the ... urging adults, especially those with lung disease, to ...
Breaking Medicine Technology:PTC Therapeutics to Participate at Upcoming Investor Conferences 2Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 2Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 3Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 4Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 5Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 6Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 7Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 8Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 9Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 10Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 11Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 12Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 13Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 14Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 15Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 16Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 17Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 18Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 19Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 20Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 21Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 22Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 23American Lung Association Urges Adults with Lung Disease to Consult their Health Care Provider to Stay Current on Vaccinations 2American Lung Association Urges Adults with Lung Disease to Consult their Health Care Provider to Stay Current on Vaccinations 3
(Date:8/21/2014)... Beverly Hills Medical Center of Kuwait is ... patients TearLab, a new diagnostic option for measuring tear production ... , “ TearLab is a revolutionary new testing method ... measure the amount of tears a patient produces and take ... Zein, Medical Director at the Kuwait medical center. “The test ...
(Date:8/21/2014)... CA (PRWEB) August 21, 2014 Prosthodontists Dr. ... to India next month to provide workshops on full mouth ... southern India city of Bangalore in late September. , “Full ... “Full mouth rehabilitation means making sure all of the elements ... bones – all work together.” , Dr. Jivraj, who has ...
(Date:8/21/2014)... 2014 Atlantic Information Services, Inc. (AIS) ... News and The AIS Report on Blue Cross & ... Blue Shield Association or its member companies) — is ... in AIS’s Management Insight Series. Bundled Payment Models: ... two insurers — Horizon Healthcare Services, Inc. and Arkansas ...
(Date:8/21/2014)... If chocolate is good for the brain ... very happy and healthy. Tracie is the latest winner of ... She and three of her coworkers will be enjoying an ... world-famous Chocolate Spa® at The Hotel Hershey® in Hershey, Pennsylvania. ... in the ambulatory surgery center at Connecticut Children’s Medical Center ...
(Date:8/21/2014)... Inc. magazine ranked Centurion Service Group No. 3745 ... of the nation's fastest-growing private companies. The list represents ... of the economy—America’s independent entrepreneurs. Companies such as Yelp, ... other well-known names gained early exposure as members of ... been named to the Inc. 5000 list. We have ...
Breaking Medicine News(10 mins):Health News:Beverly Hills Kuwait is the First Medical Center in Kuwait with Access to TearLab 2Health News:Oxnard Cosmetic Dentist Earns Invitation to Speak in India 2Health News:Oxnard Cosmetic Dentist Earns Invitation to Speak in India 3Health News:Oxnard Cosmetic Dentist Earns Invitation to Speak in India 4Health News:New AIS Report Highlights Two Case Studies of Bundled Payment Models 2Health News:Connecticut Nurse Wins a Sweet Prize from California Casualty 2Health News:Centurion Service Group Named to Inc. Magazine's List of the Nation's Fastest-Growing Private Companies 2Health News:Centurion Service Group Named to Inc. Magazine's List of the Nation's Fastest-Growing Private Companies 3Health News:Centurion Service Group Named to Inc. Magazine's List of the Nation's Fastest-Growing Private Companies 4
... Louisiana Tumor Registry (LTR) at the LSU Health Sciences ... awarded a $12 million contract over seven years by ... a SEER (Surveillance, Epidemiology and End Results) Program-designated cancer ... in the United States., "The SEER Program is the ...
... An experimental vaccine based on a virus that causes ... in some cases of advanced cancer, according to researchers ... is able to stimulate an immune response, even in ... most patients with advanced cancer experience. Scientists ...
... refuse or request the withdrawal of any unwanted treatment. In ... Clinic Proceedings , investigators explore the legal and ethical permissibility ... assist device (VAD). The left-VAD (LVAD) is a ... heart failure who are awaiting a heart transplant. This technology ...
... controversial hypothesis that venous congestionchronic cerebrospinal venous insufficiency ... This theory has resulted in many MS patients ... unproven by clinical trials. The studies refuting the ... on the subject, are available today in ...
... of healing according to the way they cope and their ... health psychologist at The University of Nottingham. The large ... has shown that the way patients cope with the condition ... or worsens. The work by Professor Kavita Vedhara from ...
... able to significantly reduce the radiation dose associated with ... one day dose optimization workshop provided by the Royal ... supported by the local state health department, according to ... Journal of the American College of Radiology (www.jacr.org). ...
Cached Medicine News:Health News:LA Tumor Registry at LSUHSC awarded $12 million SEER contract by NCI 2Health News:LA Tumor Registry at LSUHSC awarded $12 million SEER contract by NCI 3Health News:Alphavirus-based vaccine may slow some cancers 2Health News:Mayo Clinic finds withdrawing ventricular assist device support ethical 2Health News:New studies question vascular multiple sclerosis hypothesis and treatment 2Health News:New studies question vascular multiple sclerosis hypothesis and treatment 3Health News:Mind over matter? The psychology of healing 2
300 L, Racked, 96 tips/rack Recommended for 250 and 300 L pipettes....
... been designed to optimize the accuracy and ... tip products is widely recognized by customers ... been extended over the years and now ... special tips including filter tips, certified pure ...
... a rack for single- and multichannel ... Racks: Can be steam sterilized at ... with an 8 x 12 row ... specifically designed to ensure proper connection ...
... Universal Softfit(tm) Design to fit most ... Compatibility Biohit Electronic (Limited Draw) ... Multi-Channel 5-50ul Capp Aero 50ul ... Titerman 4908 5-50ul Finnpipette Multi-Channel 5-50ul ...
Medicine Products: